The scientist’s investigation covers issues in Virology, Ebola virus, Microbiology, Marburg virus and Filoviridae. His Virology research is multidisciplinary, relying on both Immunology and Immunity. In the subject of general Ebola virus, his work in Ebolavirus is often linked to Wild type, thereby combining diverse domains of study.
His Ebolavirus research is multidisciplinary, incorporating perspectives in Antibody and Viral replication. Kelly L. Warfield works mostly in the field of Microbiology, limiting it down to concerns involving Immune system and, occasionally, CD80, CD40 and Parvovirus. His Filoviridae study frequently draws connections to other fields, such as Mononegavirales.
His primary areas of study are Virology, Ebola virus, Virus, Filoviridae and Immunology. He has included themes like Antibody and Microbiology in his Virology study. Kelly L. Warfield interconnects Virus classification and Viral Vaccine, Vaccination in the investigation of issues within Ebola virus.
His biological study deals with issues like Mononegavirales, which deal with fields such as Ebola Hemorrhagic Fever. His research in Immunology focuses on subjects like Cytotoxic T cell, which are connected to T cell. His research investigates the connection between Marburgvirus and topics such as Marburg virus disease that intersect with issues in Serial passage.
His primary areas of investigation include Virology, Virus, Dengue fever, Iminosugar and Antibody. The Virology study combines topics in areas such as Epitope and Monoclonal antibody. In general Virus, his work in Tropism, Alphavirus and Chikungunya is often linked to Heparan sulfate linking many areas of study.
His Dengue fever research incorporates elements of Influenza A virus, Mutation rate and In vivo. His research integrates issues of Marburg virus disease and Viremia in his study of Marburgvirus. His study in Ebola virus focuses on Ebolavirus in particular.
Kelly L. Warfield spends much of his time researching Virology, Monoclonal antibody, Antibody, Epitope and Ebolavirus. Kelly L. Warfield combines subjects such as Virus classification and Linear epitope with his study of Virology. His Linear epitope research includes elements of Marburgvirus and Bundibugyo virus.
His Ebolavirus study is focused on Ebola virus in general. His research in Vaccination focuses on subjects like Alum adjuvant, which are connected to Reactogenicity. His Virus study necessitates a more in-depth grasp of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
Mansour Mohamadzadeh;Scott Olson;Warren V. Kalina;Gordon Ruthel.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Rotavirus antigenaemia and viraemia: a common event?
Sarah E Blutt;Carl D Kirkwood;Viviana Parreño;Kelly L Warfield.
The Lancet (2003)
Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection
Brian R. Amman;Serena A. Carroll;Zachary D. Reed;Tara K. Sealy.
PLOS Pathogens (2012)
Ebola Virus-Like Particle-Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge
Kelly L. Warfield;Dana L. Swenson;Gene G. Olinger;Warren V. Kalina.
The Journal of Infectious Diseases (2007)
Ebola virus-like particles protect from lethal Ebola virus infection
Kelly L. Warfield;Catharine M. Bosio;Brent C. Welcher;Emily M. Deal.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Advanced antisense therapies for postexposure protection against lethal filovirus infections
Travis K Warren;Kelly L Warfield;Jay Wells;Dana L Swenson.
Nature Medicine (2010)
Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers
Kelly L Warfield;Dana L Swenson;Gene G Olinger;Donald K Nichols.
PLOS Pathogens (2006)
Role of natural killer cells in innate protection against lethal ebola virus infection.
Kelly L. Warfield;Jeremy G. Perkins;Dana L. Swenson;Emily M. Deal.
Journal of Experimental Medicine (2004)
Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections
Dana L. Swenson;Danher Wang;Min Luo;Kelly L. Warfield.
Clinical and Vaccine Immunology (2008)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
Dana L. Swenson;Kelly L. Warfield;Diane L. Negley;Alan Schmaljohn.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: